Healthcare & Life Sciences
MapLight Therapeutics
United Statesmaplightrx.com
MapLight Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 2 tracked investors.
activeseries-c-plus
series-c-plus
Stage
2
Investors
About MapLight Therapeutics
MapLight Therapeutics is a company headquartered in the United States. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
MapLight Therapeutics is a clinical-stage biotechnology company developing novel therapeutics for neuropsychiatric and neurological disorders such as schizophrenia, Alzheimer's, and Parkinson's disease.
Explore MapLight Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.